Anna Szumera‐Ciećkiewicz

2.2k total citations
127 papers, 1.1k citations indexed

About

Anna Szumera‐Ciećkiewicz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Anna Szumera‐Ciećkiewicz has authored 127 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 46 papers in Pulmonary and Respiratory Medicine and 26 papers in Molecular Biology. Recurrent topics in Anna Szumera‐Ciećkiewicz's work include Sarcoma Diagnosis and Treatment (36 papers), Cutaneous Melanoma Detection and Management (19 papers) and Lymphoma Diagnosis and Treatment (17 papers). Anna Szumera‐Ciećkiewicz is often cited by papers focused on Sarcoma Diagnosis and Treatment (36 papers), Cutaneous Melanoma Detection and Management (19 papers) and Lymphoma Diagnosis and Treatment (17 papers). Anna Szumera‐Ciećkiewicz collaborates with scholars based in Poland, Italy and Hungary. Anna Szumera‐Ciećkiewicz's co-authors include Piotr Rutkowski, Anna M. Czarnecka, Monika Prochorec‐Sobieszek, Mateusz Spałek, Aneta Borkowska, Konrad Ptaszyński, Paweł Teterycz, Michał Wągrodzki, Tomasz Świtaj and Hanna Koseła-Paterczyk and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Analytical Chemistry.

In The Last Decade

Anna Szumera‐Ciećkiewicz

117 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Szumera‐Ciećkiewicz Poland 20 528 415 294 203 200 127 1.1k
O. Hans Iwenofu United States 21 502 1.0× 410 1.0× 618 2.1× 202 1.0× 166 0.8× 80 1.5k
Darya Buehler United States 20 542 1.0× 354 0.9× 398 1.4× 76 0.4× 113 0.6× 69 1.4k
Amy S. Duffield United States 22 343 0.6× 209 0.5× 570 1.9× 84 0.4× 261 1.3× 86 1.5k
Andrew S. Brohl United States 22 1.2k 2.4× 528 1.3× 426 1.4× 103 0.5× 231 1.2× 100 2.0k
Michaela Nathrath Germany 24 647 1.2× 591 1.4× 689 2.3× 215 1.1× 313 1.6× 70 1.8k
Antonio D’Antonio Italy 18 640 1.2× 291 0.7× 385 1.3× 110 0.5× 156 0.8× 96 1.3k
Katsushige Yamashiro Japan 22 423 0.8× 606 1.5× 171 0.6× 242 1.2× 147 0.7× 78 1.4k
Zahid Kaleem United States 21 352 0.7× 316 0.8× 329 1.1× 106 0.5× 418 2.1× 49 1.3k
Michael D. Linden United States 21 460 0.9× 442 1.1× 311 1.1× 146 0.7× 299 1.5× 53 1.3k
Till S. Clauditz Germany 20 550 1.0× 274 0.7× 388 1.3× 63 0.3× 140 0.7× 90 1.2k

Countries citing papers authored by Anna Szumera‐Ciećkiewicz

Since Specialization
Citations

This map shows the geographic impact of Anna Szumera‐Ciećkiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Szumera‐Ciećkiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Szumera‐Ciećkiewicz more than expected).

Fields of papers citing papers by Anna Szumera‐Ciećkiewicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Szumera‐Ciećkiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Szumera‐Ciećkiewicz. The network helps show where Anna Szumera‐Ciećkiewicz may publish in the future.

Co-authorship network of co-authors of Anna Szumera‐Ciećkiewicz

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Szumera‐Ciećkiewicz. A scholar is included among the top collaborators of Anna Szumera‐Ciećkiewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Szumera‐Ciećkiewicz. Anna Szumera‐Ciećkiewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Czarnecka, Anna M., et al.. (2024). Distal and proximal epithelioid sarcoma — differences in diagnosis and similarities in treatment. Oncology in Clinical Practice. 21(1). 60–70. 1 indexed citations
3.
Czarnecka, Anna M., Anna Szumera‐Ciećkiewicz, Tomasz Świtaj, et al.. (2024). Long‐term efficacy of neoadjuvant–adjuvant targeted therapy in borderline resectable stage IIIB–D and IV melanoma. Cancer. 130(20). 3463–3472. 1 indexed citations
4.
Ortenzi, Valerio, Nicola Montemurro, Francesco Pasqualetti, et al.. (2023). The Prognostic Impact of Gender, Therapeutic Strategies, Molecular Background, and Tumor-Infiltrating Lymphocytes in Glioblastoma: A Still Unsolved Jigsaw. Genes. 14(2). 501–501. 7 indexed citations
5.
Świtaj, Tomasz, Mateusz Spałek, Joanna Radzikowska, et al.. (2023). Diagnosis and treatment of rhabdomyosarcomas. Oncology in Clinical Practice. 19(4). 250–279. 2 indexed citations
6.
Rutkowski, Piotr, Anna Szumera‐Ciećkiewicz, Agnieszka Zając, et al.. (2023). 1969P Intratumoral immune infiltrates in chondrosarcoma (ChS). Annals of Oncology. 34. S1052–S1052. 2 indexed citations
7.
Szumera‐Ciećkiewicz, Anna, Mateusz Spałek, Michał Wągrodzki, et al.. (2023). Predictive Biomarkers of Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Soft Tissue Sarcomas. Cancers. 15(11). 2960–2960. 5 indexed citations
8.
Spałek, Mateusz, Kjetil Boye, Anna Szumera‐Ciećkiewicz, et al.. (2023). Diagnostics and Treatment of Extrameningeal Solitary Fibrous Tumors. Cancers. 15(24). 5854–5854. 7 indexed citations
9.
Mandalà, Mario, Piotr Rutkowski, Francesca Galli, et al.. (2022). Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study. ESMO Open. 7(3). 100469–100469. 4 indexed citations
10.
Sobczuk, Paweł, Katarzyna Kozak, Tomasz Świtaj, et al.. (2022). Treatment of Locally Advanced Merkel Cell Carcinoma—A Multi-Center Study. Cancers. 14(2). 422–422. 3 indexed citations
12.
Kolmus, Krzysztof, Krzysztof Goryca, Anna Szumera‐Ciećkiewicz, et al.. (2021). Concurrent depletion of Vps37 proteins evokes ESCRT-I destabilization and profound cellular stress responses. Journal of Cell Science. 134(1). 16 indexed citations
13.
Zając, Agnieszka, Mateusz Spałek, Michał Fiedorowicz, et al.. (2021). Chondrosarcoma-from Molecular Pathology to Novel Therapies. Cancers. 13(10). 2390–2390. 49 indexed citations
14.
Świtaj, Tomasz, Paweł Teterycz, Mateusz Spałek, et al.. (2021). Feasibility and Long-Term Efficacy of PEComa Treatment—20 Years of Experience. Journal of Clinical Medicine. 10(10). 2200–2200. 15 indexed citations
15.
Kowalik, Artur, Monika Jurkowska, Ewa Mierzejewska, et al.. (2020). The prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve clinical stage III cutaneous melanoma. Melanoma Research. 30(4). 348–357. 2 indexed citations
16.
Jabłońska, Ewa, Emilia Białopiotrowicz, Maciej Szydłowski, et al.. (2020). DEPTOR is a microRNA-155 target regulating migration and cytokine production in diffuse large B-cell lymphoma cells. Experimental Hematology. 88. 56–67.e2. 12 indexed citations
17.
Teterycz, Paweł, Anna M. Czarnecka, Alice Indini, et al.. (2020). Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy. Cancers. 12(11). 3131–3131. 25 indexed citations
18.
Borkowska, Aneta, Anna Szumera‐Ciećkiewicz, Mateusz Spałek, et al.. (2020). Clinicopathological Features and Prognostic Factors of Primary Acral Melanomas in Caucasians. Journal of Clinical Medicine. 9(9). 2996–2996. 10 indexed citations
19.
Ptaszyński, Konrad, et al.. (2009). Her2, EGFR and TOPIIA gene amplification and protein expression in synovial sarcoma before and after combined treatment.. PubMed. 60(1). 10–8. 4 indexed citations
20.
Szumera‐Ciećkiewicz, Anna, et al.. (2008). Endobronchial metastasis from hepatocellular carcinoma - a case description with literature review.. PubMed Central. 6(10). 20–20. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026